Alpha 2.0
Login Register
» Authors » Magdolna Szilvia Kovacs

Magdolna Szilvia Kovacs

Explore the profile of Magdolna Szilvia Kovacs including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 23
Followers 0
Related Specialties
Rheumatology
General Medicine
Health Services
Co-Authors
Arne Schafer
Martin Feuchtenberger
Axel Nigg
Anna Eder
Martina Prelog
Giovanni Almanzar
Published In
Clin Rheumatol
Rheumatol Int
J Clin Med
Rheumatol Adv Pract
J Ultrasound
Affiliations
Soon will be listed here.
Recent Articles
1.
Detection of substantial numbers of latent tuberculosis and positive hepatitis B serology results in rheumatology patients preparing to receive intensified immunosuppressive therapy in a low-prevalence country: why screening still matters
Feuchtenberger M, Kovacs M, Nigg A, Schafer A
Clin Rheumatol . 2025 Feb; PMID: 39998600
Introduction /objectives: International guidelines recommend screening for latent tuberculosis infection (LTBI) and chronic viral hepatitis infections before initiating intensified immunosuppressive therapy. We assessed the prevalence of positive screening tests for...
2.
Patient-Reported Outcomes of Depression and Fibromyalgia Symptoms Do Not Predict Non-Inflammatory versus Inflammatory Diagnoses at Initial Rheumatology Consultation
Schafer A, Kovacs M, Nigg A, Feuchtenberger M
Healthcare (Basel) . 2024 Oct; 12(19). PMID: 39408128
Objective: The objective of this study was to assess the potential value of patient-reported outcomes (PROs) of depression, fibromyalgia symptoms, and pain in predicting non-inflammatory vs. inflammatory diagnoses in rheumatology...
3.
Real-world data on tolerability of COVID-19 vaccination in patients with rheumatoid arthritis based on patient-reported outcomes
Feuchtenberger M, Kovacs M, Eder A, Nigg A, Almanzar G, Prelog M, et al.
Rheumatol Adv Pract . 2024 Sep; 8(4):rkae111. PMID: 39282624
Objectives: To assess tolerability of COVID-19 vaccination in patients with RA and controls based on patient-reported outcomes (PROs). Methods: In total, 266 study participants were included at 6 ± 1 ...
4.
Prioritising Appointments by Telephone Interview: Duration from Symptom Onset to Appointment Request Predicts Likelihood of Inflammatory Rheumatic Disease
Feuchtenberger M, Kovacs M, Nigg A, Schafer A
J Clin Med . 2024 Aug; 13(15). PMID: 39124816
This study aims to determine the rate of inflammatory rheumatic diseases (IRDs) in a cohort of initial referrals and the efficacy of prioritising appointments to the early arthritis clinic (EAC)...
5.
Longitudinal assessment of liver stiffness using ARFI technique does not support increased risk of fibrosis in rheumatoid arthritis patients on methotrexate
Schafer A, Kovacs M, Eder A, Nigg A, Feuchtenberger M
J Ultrasound . 2024 Jan; PMID: 38227146
Aims: To assess the liver stiffness in patients with rheumatoid arthritis treated with methotrexate monotherapy using non-invasive, ultrasound-based elastography (acoustic radiation force impulse (ARFI) imaging) in a longitudinal approach. Methods:...
6.
Janus kinase (JAK) inhibitors significantly reduce the humoral vaccination response against SARS-CoV-2 in patients with rheumatoid arthritis
Schafer A, Kovacs M, Eder A, Nigg A, Feuchtenberger M
Clin Rheumatol . 2022 Aug; 41(12):3707-3714. PMID: 35965290
Objectives: Recently, a number of studies have explored the possible attenuation of the immune response by disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA). Our study objective was...
7.
Methotrexate significantly reduces the humoral vaccination response against SARS-CoV-2 in older but not younger patients with rheumatoid arthritis
Feuchtenberger M, Kovacs M, Eder A, Nigg A, Schafer A
Rheumatol Int . 2022 Apr; 42(6):959-966. PMID: 35429290
To assess the humoral response to vaccination against SARS-CoV-2 in patients with rheumatoid arthritis treated with methotrexate (MTX). In total, 142 fully vaccinated individuals were included at 6 ± 1 ...